Advertisement

Related Videos

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Advertisement

Advertisement




Oct
16
Today In Oncology
AML: Alliance Global Study Challenges Age-Based Treatment Decisions
New AACI President-Elect Selected; Two Cancer Center Leaders Join Board
10-Year Incidence of Second Cancers in HPV Oropharyngeal Cancer
Individuals With Rare Cancers Present Distinct Diagnosis Patterns; Many Experience Treatment Delays
Combination Therapies for Diffuse Large B-Cell Lymphoma 5-Year Outcomes of POLARIX Trial
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo